Antoine Leuzy

affiliated with the university
More filtering options
  1. 2021
  2. The impact of demographic, clinical, genetic, and imaging variables on tau PET status

    Rik Ossenkoppele, Antoine Leuzy, Hanna Cho, Carole H. Sudre, Olof Strandberg, Ruben Smith, Sebastian Palmqvist, Niklas Mattsson-Carlgren, Tomas Olsson, Jonas Jögi, Erik Stormrud, Young Hoon Ryu, Jae Yong Choi, Adam L. Boxer, Maria L. Gorno-Tempini, Bruce L. Miller, David Soleimani-Meigooni, Leonardo Iaccarino, Renaud La Joie, Edilio Borroni & 7 others, Gregory Klein, Michael J. Pontecorvo, Michael D. Devous, Sylvia Villeneuve, Chul Hyoung Lyoo, Gil D. Rabinovici & Oskar Hansson, 2021 Jul 1, In: European Journal of Nuclear Medicine and Molecular Imaging. 48, 7, p. 2245-2258 14 p.

    Research output: Contribution to journalArticle

  3. A multicenter comparison of [18F]flortaucipir, [18F]RO948, and [18F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis

    Antoine Leuzy, Tharick A. Pascoal, Olof Strandberg, Philip Insel, Ruben Smith, Niklas Mattsson-Carlgren, Andréa L. Benedet, Hannah Cho, Chul H. Lyoo, Renaud La Joie, Gil D. Rabinovici, Rik Ossenkoppele, Pedro Rosa-Neto & Oskar Hansson, 2021 Jul, In: European Journal of Nuclear Medicine and Molecular Imaging. 48, 7, p. 2295-2305 11 p.

    Research output: Contribution to journalArticle

  4. Sex differences in off-target binding using tau positron emission tomography

    Ruben Smith, Olof Strandberg, Antoine Leuzy, Tobey J. Betthauser, Sterling C. Johnson, Joana B. Pereira & Oskar Hansson, 2021 Jan, In: NeuroImage: Clinical. 31, 102708.

    Research output: Contribution to journalArticle

  5. 2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework

    A. Leuzy, N. J. Ashton, N. Mattsson-Carlgren, A. Dodich, M. Boccardi, J. Corre, A. Drzezga, A. Nordberg, R. Ossenkoppele, H. Zetterberg, K. Blennow, G. B. Frisoni, V. Garibotto & O. Hansson, 2021, In: European Journal of Nuclear Medicine and Molecular Imaging.

    Research output: Contribution to journalReview article

  6. Detecting amyloid positivity in early Alzheimer's disease using combinations of plasma Aβ42/Aβ40 and p-tau

    Shorena Janelidze, Sebastian Palmqvist, Antoine Leuzy, Erik Stomrud, Inge M.W. Verberk, Henrik Zetterberg, Nicholas J. Ashton, Pedro Pesini, Leticia Sarasa, José Antonio Allué, Charlotte E. Teunissen, Jeffrey L. Dage, Kaj Blennow, Niklas Mattsson-Carlgren & Oskar Hansson, 2021, In: Alzheimer's and Dementia.

    Research output: Contribution to journalArticle

  7. Heterogeneous distribution of tau pathology in the behavioural variant of Alzheimer's disease

    Ellen Singleton, Oskar Hansson, Yolande A.L. Pijnenburg, Renaud La Joie, William G. Mantyh, Pontus Tideman, Erik Stomrud, Antoine Leuzy, Maurits Johansson, Olof Strandberg, Ruben Smith, Evi Berendrecht, Bruce L. Miller, Leonardo Iaccarino, Lauren Edwards, Amelia Strom, Emma E. Wolters, Emma Coomans, Denise Visser, Sandeep S.V. Golla & 9 others, Hayel Tuncel, Femke Bouwman, John Cornelis Van Swieten, Janne M. Papma, Bart Van Berckel, Philip Scheltens, Anke A. Dijkstra, Gil D. Rabinovici & Rik Ossenkoppele, 2021, (Accepted/In press) In: Journal of Neurology, Neurosurgery and Psychiatry.

    Research output: Contribution to journalArticle

  8. The strategic biomarker roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update

    Marina Boccardi, Alessandra Dodich, Emiliano Albanese, Angèle Gayet-Ageron, Cristina Festari, Nicholas J. Ashton, Gérard N. Bischof, Konstantinos Chiotis, Antoine Leuzy, Emma E. Wolters, Martin A. Walter, Gil D. Rabinovici, Maria Carrillo, Alexander Drzezga, Oskar Hansson, Agneta Nordberg, Rik Ossenkoppele, Victor L. Villemagne, Bengt Winblad, Giovanni B. Frisoni & 1 others, Valentina Garibotto, 2021, In: European Journal of Nuclear Medicine and Molecular Imaging.

    Research output: Contribution to journalArticle

  9. The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers

    N. J. Ashton, A. Leuzy, T. K. Karikari, N. Mattsson-Carlgren, A. Dodich, M. Boccardi, J. Corre, A. Drzezga, A. Nordberg, R. Ossenkoppele, H. Zetterberg, K. Blennow, G. B. Frisoni, V. Garibotto & O. Hansson, 2021, In: European Journal of Nuclear Medicine and Molecular Imaging.

    Research output: Contribution to journalReview article

  10. 2020
  11. Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders

    Sebastian Palmqvist, Shorena Janelidze, Yakeel T. Quiroz, Henrik Zetterberg, Francisco Lopera, Erik Stomrud, Yi Su, Yinghua Chen, Geidy E. Serrano, Antoine Leuzy, Niklas Mattsson-Carlgren, Olof Strandberg, Ruben Smith, Andres Villegas, Diego Sepulveda-Falla, Xiyun Chai, Nicholas K. Proctor, Thomas G. Beach, Kaj Blennow, Jeffrey L. Dage & 2 others, Eric M. Reiman & Oskar Hansson, 2020 Aug 25, In: JAMA - Journal of the American Medical Association. 324, 8, p. 772-781 10 p.

    Research output: Contribution to journalArticle

  12. Propagation of Tau Pathology: Integrating Insights From Postmortem and In Vivo Studies

    Thomas Vogels, Antoine Leuzy, Claudia Cicognola, Nicholas J. Ashton, Tomas Smolek, Michal Novak, Kaj Blennow, Henrik Zetterberg, Tomas Hromadka, Norbert Zilka & Michael Schöll, 2020 May, In: Biological Psychiatry. 87, 9, p. 808-818 11 p.

    Research output: Contribution to journalReview article

  13. An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders

    Nicholas J. Ashton, Abdul Hye, Anto P. Rajkumar, Antoine Leuzy, Stuart Snowden, Marc Suárez-Calvet, Thomas K. Karikari, Michael Schöll, Renaud La Joie, Gil D. Rabinovici, Kina Höglund, Clive Ballard, Tibor Hortobágyi, Per Svenningsson, Kaj Blennow, Henrik Zetterberg & Dag Aarsland, 2020, In: Nature Reviews Neurology. 16, 5, p. 265-284 20 p.

    Research output: Contribution to journalReview article

  14. Derivation and utility of an Aβ-PET pathology accumulation index to estimate Aβ load

    Antoine Leuzy, Johan Lilja, Christopher J. Buckley, Rik Ossenkoppele, Sebastian Palmqvist, Mark Battle, Gill Farrar, Dietmar R. Thal, Shorena Janelidze, Erik Stomrud, Olof Strandberg, Ruben Smith & Oskar Hansson, 2020, In: Neurology. 95, 21, p. e2834-e2844

    Research output: Contribution to journalArticle

  15. Disturbances in brain energy metabolism in insulin resistance and diabetes and Alzheimer's disease — Learnings from brain imaging biomarkers

    Kerstin Heurling, Edvin Johansson & Antoine Leuzy, 2020, In: International Review of Neurobiology. 154, p. 111-130 20 p.

    Research output: Contribution to journalReview article

  16. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease

    Andreá L. Benedet, Antoine Leuzy, Tharick A. Pascoal, Nicholas J. Ashton, Sulantha Mathotaarachchi, Melissa Savard, Joseph Therriault, Min Su Kang, Mira Chamoun, Michael Schöll, Eduardo R. Zimmer, Serge Gauthier, Aurélie Labbe, Henrik Zetterberg, Pedro Rosa-Neto & Kaj Blennow, 2020, In: Brain. 143, 12, p. 3793-3804 12 p.

    Research output: Contribution to journalArticle

  17. The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects

    Ruben Smith, Olof Strandberg, Niklas Mattsson-Carlgren, Antoine Leuzy, Sebastian Palmqvist, Michael J. Pontecorvo, Michael D. Devous, Rik Ossenkoppele & Oskar Hansson, 2020, In: Brain. 143, 12, p. 3805-3815 11 p.

    Research output: Contribution to journalArticle

  18. 2019
  19. Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease

    Antoine Leuzy, Claudia Cicognola, Konstantinos Chiotis, Laure Saint-Aubert, Laetitia Lemoine, Niels Andreasen, Henrik Zetterberg, Keqiang Ye, Kaj Blennow, Kina Höglund & Agneta Nordberg, 2019 May 1, In: European Journal of Nuclear Medicine and Molecular Imaging. 46, 5, p. 1152-1163 12 p.

    Research output: Contribution to journalArticle

  20. Plasma neurofilament light associates with Alzheimer's disease metabolic decline in amyloid-positive individuals

    Andréa L. Benedet, Nicholas J. Ashton, Tharick A. Pascoal, Antoine Leuzy, Sulantha Mathotaarachchi, Min S. Kang, Joseph Therriault, Melissa Savard, Mira Chamoun, Michael Schöll, Eduardo R. Zimmer, Serge Gauthier, Aurélie Labbe, Henrik Zetterberg, Kaj Blennow, Pedro R. Neto & Alzheimer's Disease Neuroimaging Initiative Alzheimer's Disease Neuroimaging Initiative, 2019, In: Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 11, p. 679-689 11 p.

    Research output: Contribution to journalArticle

  21. Synaptic vesicle protein 2A as a potential biomarker in synaptopathies

    Kerstin Heurling, Nicholas J. Ashton, Antoine Leuzy, Eduardo R. Zimmer, Kaj Blennow, Henrik Zetterberg, Jonas Eriksson, Mark Lubberink & Michael Schöll, 2019, In: Molecular and Cellular Neuroscience. 97, p. 34-42

    Research output: Contribution to journalReview article